Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Pseudomonas aeruginosa

Identifiers: BioSample: SAMN04014936; Sample name: FDA-CDC-AR_0095; SRA: SRS1350031

Organism: Pseudomonas aeruginosa
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Pseudomonadales; Pseudomonadaceae; Pseudomonas; Pseudomonas aeruginosa group

Attributes

BioProject: PRJNA292904 Gram Negative Carbapenemase Detection Genome sequencing and assembly
Retrieve all samples from this project

Submission: Centers for Disease Control and Prevention, Brian Yoo; 2015-08-27

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Testing standard
amikacin	susceptible	<=	1	mg/L	MIC	CLSI
amoxicillin-clavulanic acid	not defined	>	32/16	mg/L	MIC	CLSI
ampicillin	not defined	>	32	mg/L	MIC	CLSI
ampicillin-sulbactam	not defined	>	32/16	mg/L	MIC	CLSI
aztreonam	resistant	==	32	mg/L	MIC	CLSI
cefazolin	not defined	>	8	mg/L	MIC	CLSI
cefepime	susceptible	==	8	mg/L	MIC	CLSI
cefotaxime	not defined	>	64	mg/L	MIC	CLSI
cefoxitin	not defined	>	16	mg/L	MIC	CLSI
ceftazidime	susceptible	==	8	mg/L	MIC	CLSI
ceftriaxone	not defined	>	32	mg/L	MIC	CLSI
ciprofloxacin	resistant	>	8	mg/L	MIC	CLSI
colistin	susceptible	==	2	mg/L	MIC	CLSI
doripenem	intermediate	==	4	mg/L	MIC	CLSI
ertapenem	not defined	>	8	mg/L	MIC	CLSI
gentamicin	susceptible	<=	0.25	mg/L	MIC	CLSI
imipenem	resistant	==	32	mg/L	MIC	CLSI
levofloxacin	resistant	>	8	mg/L	MIC	CLSI
meropenem	resistant	>	8	mg/L	MIC	CLSI
piperacillin-tazobactam	intermediate	==	32/4	mg/L	MIC	CLSI
polymyxin B	susceptible	==	2	mg/L	MIC	CLSI
tetracycline	not defined	==	32	mg/L	MIC	CLSI
tigecycline	not defined	==	4	mg/L	MIC	CLSI
tobramycin	susceptible	<=	0.5	mg/L	MIC	CLSI
trimethoprim-sulfamethoxazole	not defined	>	8/152	mg/L	MIC	CLSI